Effect of tumor necrosis factor-alpha on the permeability of bovine brain microvessel endothelial cell monolayers

Neurological Research

Volumn 19, Issue 4, 1997, Pages 369-376

  Anda, Takeo ^a   Yamashita, Hiromi ^a   Khalid, Humayun ^a   Tsutsumi, Keisuke ^a   Fujita, Hideshi ^a   Tokunaga, Yoshiharu ^a   Shibata, Shobu ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Blood brain barrier; Bovine brain microvessel endothelial cell; Cisplatin; Tumor necrosis factor alpha

Indexed keywords

CISPLATIN; FLUORESCEIN ISOTHIOCYANATE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN TUMOR; CATTLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MIXTURE; DRUG TRANSPORT; ENDOTHELIUM CELL; INFLAMMATION; MONOLAYER CULTURE; NONHUMAN;

EID: 0030795802     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1080/01616412.1997.11758599     Document Type: Article

References (10)

1. Brightman MW, Reese TS. Junctions between intimately opposed cell membranes in the vertebrate brain. J Cell Biol 1969; 40: 648-677
2. Boiardi A, Silvani A, Milanesi I, Botturi M, Broggi G. Primary glial tumor patients treated by combining cis-platin and etoposide. J NeuroOncol 1991; 11: 165-170
3. Dropcho EJ, Rosenfeld SS, Morawetz RB, Vitek J, Brothers M, Gorum T, Bell S, Gillespie GY, Glantz M, Mahaley MS Jr. Preradiation intracarotid cisplatin treatment of newly diagnosed anaplastic gliomas. The CNS Cancer Consortium. J Clin Oncol 1992; 10: 452-458
4. Spence AM, Berger MS, Livingston RB, Ali-Osman F, Griffin B. Phase II evaluation of high-dose intravenous cisplatin for treatment of adult malignant gliomas recurrent after chloroethylnitrosourea failure. J NeuroOncol 1992; 12: 187-191
5. Brett J, Gerlach H, Nawroth P, Steinberg S, Godman G, Stern D. Tumor necrosis factor/cachectin increases permeability of endothelial monolayers by a mechanism involving regulatory G proteins. J Exp Med 1989; 169: 1977-1991
6. Langeler EG, Fiers W, van Hinsbergh VW. Effects of tumor necrosis factor on prostacyclin production and the barrier function of human endothelial cell monolayers. Arteriosclerosis Thrombosis 1991; 11: 872-881
7. Neal ML, Fiera RA, Matthews N. Involvement of phospholipase A2 activation in tumor cell killing by tumor necrosis factor, Immunology 1988; 64: 81-85
8. Gamble JR, Harlan JM, Klebanoff SJ, Vadas MA. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci (USA) 1985; 78: 8667-8671
9. Movat HZ. Tumor necrosis factor and interleukin-1: Role in acute inflammation and microvascular injury. J Lab Clin Med 1987; 10: 668-681
10. Shau H. Characteristics and mechanism of neutrophil-mediated cytostasis induced by tumor necrosis factor. J Immunol 1988; 141: 234-240